Significance and Innovations:1. Juvenile systemic sclerosis (jSSc) patients demonstrate significant differences between dcjSSc and lcjSSc subtype regarding frequency of skin, vascular, pulmonary and cardiac involvement.2. Physician global assessment of disease activity and damage is higher in the dcjSSc group.3. jSSc patients with overlap features are not 'protected' from major internal organ involvement and have a higher frequency of lung disease compared to those without overlap features.